Health matrix (Cleveland, Ohio : 1991)最新文献_第8页

Bending the health cost curve: the promise and peril of the Independent Payment Advisory Board. 弯曲医疗成本曲线:独立支付咨询委员会的希望与危险。

Health matrix (Cleveland, Ohio : 1991) Pub Date : 2012-01-01

Ann Marie Marciarille, J Bradford DeLong

{"title":"Bending the health cost curve: the promise and peril of the Independent Payment Advisory Board.","authors":"Ann Marie Marciarille, J Bradford DeLong","doi":"","DOIUrl":"","url":null,"abstract":"Underlying today's and the future's health-care reform debate is a consensus that America's health-care financing system is in a slow-moving but deep crisis: care appears substandard in comparison with other advanced industrial countries, and relative costs are exploding beyond all reasonable measures. The Obama Administration's Patient Protection and Affordable Care Act (ACA) attempts to grapple with both of these problems. One of ACA's key instrumentalities is the Independent Payment Advisory Board-the IPAB, designed to discover and authorize ways to reduce the rate of growth of Medicare and other categories of health spending. The IPAB is a peril. Expert boards to perform regulatory tasks in the interest of efficiency and social goals always run a high risk of being captured by the industry they are supposed to regulate. Even should it succeed at its task of reducing the rate of growth of Medicare spending, who is to say that the reductions will not come at a heavy cost in reduced quantity and effectiveness of medical care? But the IPAB also has promise. The need for a better process than our current specialist-driven one to assign value to the medical services provided by Medicare is great. The bellwether status of Medicare payment systems means that commercial insurance consumers and payors would also benefit mightily from bringing more coherent, technocratic, and cost-effectiveness oriented logic to this process. And the current system of relative Medicare reimbursement rates is, in the judgment of many, currently well out of whack. We quail when we consider the magnitude of the tasks the IPAB faces--even its initial task. Nevertheless, we remain optimistic that this administrative agency will manage to bend the long-run healthcare cost curve and moderate future price increases.","PeriodicalId":73212,"journal":{"name":"Health matrix (Cleveland, Ohio : 1991)","volume":"22 1","pages":"75-121"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30635811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Quality of health care and the role of relationships: bridging the medico-legal divide. 保健质量和关系的作用:弥合医法鸿沟。

Health matrix (Cleveland, Ohio : 1991) Pub Date : 2012-01-01

Sagit Mor, Orna Rabinovich Einy

引用次数: 0

Catching flies with vinegar: a critique of the Centers for Medicare and Medicaid self-disclosure program. 用醋抓苍蝇:对医疗保险和医疗补助自我披露计划的批评。

Health matrix (Cleveland, Ohio : 1991) Pub Date : 2012-01-01

Jean Wright Veilleux

引用次数: 0

University opposition to unfettered research: a new bedfellow for biotech? 大学反对自由研究:生物技术的新同床异梦?

Health matrix (Cleveland, Ohio : 1991) Pub Date : 2012-01-01

Katherine L Record

{"title":"University opposition to unfettered research: a new bedfellow for biotech?","authors":"Katherine L Record","doi":"","DOIUrl":"","url":null,"abstract":"This Article examines university opposition to a proposed statutory exemption to infringement liability for basic genetic research and patient care. Gene patenting has allowed patentees to bar basic genetic research, slowing the progress of developing and administering diagnostics and gene-targeting therapeutics. Debates over the merits of gene patents have been heated, most recently leading to an unprecedented invalidation of several broad patents covering all variations and use of two genes linked to breast and ovarian cancers. More important, however (as this ruling was reversed in part), are proposed statutory exemptions to infringement liability. The Department of Health and Human Services' Secretary's Advisory Committee on Genetics, Health, and Society (SACGHS) has promulgated an exemption from liability for infringement that occurs in the course of research. This exemption would promote basic research by granting academic scientists unfettered access to genetic material. The proposal does not alter the patentability of gene sequences; it merely restricts patentees from using infringement threats to stop research. Surprisingly, the Association of University Technology Managers (AUTM), an organization responsible for promoting development of university research, opposes such an exemption. The AUTM alleges that the exemption would slow research by reducing the incentive for private firms to invest in upstream discoveries made in university laboratories. Yet the exemption would do the opposite: by opening the doors to research relating to any gene segment, a research exemption would accelerate basic research. Moreover, it would not affect collaboration with private industry: where there is potential to commercialize basic research, biomedical companies would continue to license the rights to university discoveries. Thus, the AUTM's motivations in opposing the proposed research exemption are suspect. They appear to reflect either a misunderstanding of the purpose behind granting property rights to publicly funded university research, or an improper alignment with industry goals.","PeriodicalId":73212,"journal":{"name":"Health matrix (Cleveland, Ohio : 1991)","volume":"22 1","pages":"139-67"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30635814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rehabilitating opioid regulation: a prescription for the FDA's next proposal of an opioid risk evaluation and mitigation strategy (REMS). 恢复阿片类药物监管:FDA下一个阿片类药物风险评估和缓解策略(REMS)提案的处方。

Health matrix (Cleveland, Ohio : 1991) Pub Date : 2012-01-01

Hilary Homenko

引用次数: 0

Increasing consent for organ donation: mandated choice, individual autonomy, and informed consent. 增加对器官捐赠的同意:强制选择、个人自主和知情同意。